209 related articles for article (PubMed ID: 27530723)
1. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study.
Ji Y; Chen S; Xiang B; Xu Z; Jiang X; Liu X; Wang Q; Lu G; Yang L
Sci Rep; 2016 Aug; 6():31744. PubMed ID: 27530723
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome study of 61 cases.
Hoornweg MJ; Saeed P; Tanck MW; Hage JJ; Coumou AD; Van Der Horst CM
Eur J Ophthalmol; 2014; 24(6):940-7. PubMed ID: 24729139
[TBL] [Abstract][Full Text] [Related]
3. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
5. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
7. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
8. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
9. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
10. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
Tan ST; Itinteang T; Leadbitter P
Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
[TBL] [Abstract][Full Text] [Related]
11. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
12. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
Mhanna A; Franklin WH; Mancini AJ
Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
[TBL] [Abstract][Full Text] [Related]
13. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
14. A New Perspective for Infantile Hepatic Hemangioma in the Age of Propranolol: Experience at Baskent University.
Sarıalioğlu F; Yazıcı N; Erbay A; Boyvat F; Demir Ş; Özçay F; Uslu N
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):74-78. PubMed ID: 28302004
[TBL] [Abstract][Full Text] [Related]
15. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
[TBL] [Abstract][Full Text] [Related]
17. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases.
Chantharatanapiboon W
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S90-6. PubMed ID: 19253502
[TBL] [Abstract][Full Text] [Related]
18. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
19. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
20. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]